ArticleFrontiers in immunology2022

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.

Noelia Maldonado-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.